Raising the bar for disclosure of industry payments to doctors.

Competing Interests: Competing interests: We have read and understood BMJ policy on declaration of interests and have the following interests to declare: DM is a paid member of the Mental Health Advisory Committee, PHARMAC, New Zealand Government. He was paid by Atai Life Sciences for sessional supervision of a phase 1 trial of dimethyltryptamine, a psychedelic drug, in healthy volunteers. BM has acted as a paid expert witness for Health Canada in a legal case involving marketing of an unapproved drug product. Between 2019 and 2023, JL received payments for writing on the role of promotion in generating prescriptions for a legal firm. He is a member of the Board of Canadian Doctors for Medicare. He receives royalties from University of Toronto Press and James Lorimer and Co for books he has written. He is participating in research funded by the Canadian Institutes of Health Research.